The opportunity within the regulatory T-cell therapies market is projected to grow at an annualized rate of ~45%, till 2035.

Treg based therapies have become a research hotspot in the field of immunotherapy due to their ability to prevent / delay graft rejection and control autoimmune responses generated post adoptive transfer in vivo

Key companies covered in the https://www.rootsanalysis.com/reports/regulatory-t-cell-therapies-market.html

For more information please click on the following link:

https://www.rootsanalysis.com/reports/regulatory-t-cell-therapies-market.html or email [email protected]

Contact Information

Roots Analysis Private Limited

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

[email protected]